Is your child currently experiencing Crohn’s disease flare-ups? Local Crohn’s disease clinical research is testing a potential new medication to see if it may reduce swollen joints, unexplained weight loss, constant need to poop, malnutrition, and/or eye pain associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the Crohn’s disease clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for children at least 2 years of age but under 18 to join a CD study to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or CD and UC (including associated symptoms such as swollen joints, inflammation of the bowel or intestine, abdominal pain, malnutrition and/or liver disease), consider one of our Crohn’s disease (CD) research. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing moderate to severe UC flare-ups? Local Crohn’s disease (CD) study is testing a potential new medication to see if it may reduce cramping, stomach pain, abdominal pain, malnutrition, and/or liver disease associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the Crohn’s disease (CD) study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

We are looking for young people 2 to 17 years old to join a Crohn’s disease (CD) medical research study to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or Crohn’s and UC (including associated symptoms such as diarrhea, weight loss, constant need to poop, chronic fatigue and/or canker sores), consider one of our clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing Crohn’s and UC flare-ups? Local clinical research study is testing a potential new medication to see if it may reduce diarrhea with blood and pus, diarrhea, diarrhea, chronic fatigue, and/or liver disease associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

We are looking for young people aged 2 to 17 years to join a study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or Crohn’s (including associated symptoms such as diarrhea with blood and pus, abdominal cramps, diarrhea, frequent fevers and/or canker sores), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

Is your child currently experiencing UC flare-ups? Local study is testing a potential new medication to see if it may reduce diarrhea with pus, abdominal cramps, diarrhea, malnutrition, and/or anemia associated with UC.
If you’re concerned about how UC affects your child’s life, find out more about the study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

We are looking for teen to join a clinical trial to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or UC (including associated symptoms such as fever, unexplained weight loss, diarrhea, frequent fevers and/or anemia), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your teen may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing Crohn’s and UC flare-ups? Local CD research study is testing a potential new medication to see if it may reduce fatigue, perianal fistula, rectal pain, malnutrition, and/or eye pain associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the CD research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for young people 2–17 years old to join a CD clinical research to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or Crohn’s disease (including associated symptoms such as fatigue, fistula, constant need to poop, weight loss and/or eye pain), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.